Search Results - "Behrendt, Carolyn"

Toxicity profile of repeated doses of PEG-asparaginase incorporated into a pediatric-type regimen for adult acute lymphoblastic leukemia by Aldoss, Ibrahim, Douer, Dan, Behrendt, Carolyn E., Chaudhary, Preeti, Mohrbacher, Ann, Vrona, Janice, Pullarkat, Vinod

“…Despite having been long regarded as too toxic for adult patients, pediatric‐like regimens containing L‐asparaginase have resulted in improved outcomes for…”
Get full text

Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer by Ge, Xuan, Behrendt, Carolyn E, Yost, Susan E, Patel, Niki, Samoa, Raynald, Stewart, Daphne, Sedrak, Mina, Lavasani, Sayeh, Waisman, James, Yuan, Yuan, Mortimer, Joanne

“…Abstract Background Hyperglycemia is recognized as a common adverse event for patients receiving alpelisib but has been little studied outside of clinical…”
Get full text

Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles by Behrendt, Carolyn E

“…To investigate the risk of COPD among nonsmokers. Case-control study, logistic regression analysis. Third National Health and Nutrition Examination Survey,…”
Get more information

Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry by Slavin, Thomas P, Van Tongeren, Lily R, Behrendt, Carolyn E, Solomon, Ilana, Rybak, Christina, Nehoray, Bita, Kuzmich, Lili, Niell-Swiller, Mariana, Blazer, Kathleen R, Tao, Shu, Yang, Kai, Culver, Julie O, Sand, Sharon, Castillo, Danielle, Herzog, Josef, Gray, Stacy W, Weitzel, Jeffrey N

“…In germline genetic testing, variants from understudied ancestries have been disproportionately classified as being of uncertain significance. We hypothesized…”
Get full text

Are associations between psychosocial stressors and incident lung cancer attributable to smoking? by Behrendt, Carolyn E, Cosgrove, Candace M, Johnson, Norman J, Altekruse, Sean F

“…To learn whether reported associations between major psychosocial stressors and lung cancer are independent of smoking history. Subjects were at least 25 years…”
Get full text

Tumor Epigenetic Signature and Survival in Resected Gastric Cancer Patients by Woo, Yanghee, Behrendt, Carolyn E., Yang, Annie, Hahn, Maria, Goel, Ajay, Li, Haiqing, Yuan, Yate-Ching, Fong, Yuman

“…Precision oncology can identify patient-specific molecular signatures to better inform the prognosis and management of surgical cancer patients. Specifically,…”
Get full text

A copula model for joint modeling of longitudinal and time‐invariant mixed outcomes by Kürüm, Esra, Jeske, Daniel R., Behrendt, Carolyn E., Lee, Peter

“…Motivated by a preclinical study in a mouse model of breast cancer, we suggest a joint modeling framework for outcomes of mixed type and measurement structures…”
Get full text

HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia by Rainone, Michael, Behrendt, Carolyn E., Kasparian, Saro, Nguyen, Tina, Sedrak, Mina S., Lavasani, Sayeh, Stewart, Daphne B., Yuan, Yuan, Mortimer, Joanne E., Waisman, James R., Patel, Niki, Pullarkat, Vinod

“…Background Thrombocytopenia is a common adverse event on HER2-targeted therapies, fam-trastuzumab deruxtecan (T-DXd) and ado-trastuzumab emtansine (T-DM1). A…”
Get full text

Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data by Behrendt, Carolyn E., Villalona-Calero, Miguel A., Newman, Edward M., Frankel, Paul H.

“…Prior meta-analysis of stem-cell transplantation trials for renal-cell carcinoma observed that clinical outcomes vary by subjects' order of entry, specifically…”
Get full text

Germline mutations and age at onset of lung adenocarcinoma by Reckamp, Karen L., Behrendt, Carolyn E., Slavin, Thomas P., Gray, Stacy W., Castillo, Danielle K., Koczywas, Marianna, Cristea, Mihaela C., Babski, Kirsten M., Stearns, Donna, Marcum, Catherine A., Rodriguez, Yenni P., Hass, Amie J., Vecchio, Mary M., Mora, Pamela, Cervantes, Aleck E., Sand, Sharon R., Mejia, Rosa M., Tsou, Terrence C., Salgia, Ravi, Weitzel, Jeffrey N.

“…Background To identify additional at‐risk groups for lung cancer screening, which targets persons with a long history of smoking and thereby misses younger or…”
Get full text

Predicting Acute and Persistent Neuropathy Associated With Oxaliplatin by ALEJANDRO, Linh M, BEHRENDT, Carolyn E, KIM CHEN, OPENSHAW, Harry, SHIBATA, Stephen

“…We sought to predict oxaliplatin-associated peripheral neuropathy during modified FOLFOX6 (mFOLFOX6) therapy. Equal numbers of male and female patients with…”
Get full text

Severe menopausal symptoms are widespread among survivors of breast cancer treatment regardless of time since diagnosis by Mortimer, Joanne, Behrendt, Carolyn E

“…The intensity and persistence of treatment-related symptoms among breast cancer survivors is incompletely understood. The objective of the study was to…”
Get more information

Incidence of Inflammatory Breast Cancer in Women, 1992–2009, United States by Goldner, Bryan, Behrendt, Carolyn E., Schoellhammer, Hans F., Lee, Byrne, Chen, Steven L.

“…Background The annual incidence of inflammatory breast cancer (IBC) in the United States reportedly increased during the last quarter of the twentieth century…”
Get full text

Screening endoscopy finds high prevalence of Helicobacter pylori and intestinal metaplasia in Korean American with limited access to health care by Woo, Yanghee, Behrendt, Carolyn E., Trapp, Garrick, Hyun, Jae Geun, Gonda, Tamas, Fong, Yuman, Wang, Timothy

“…Background Gastric cancer (GC) is the leading cause of cancer death among Korean Americans. Prevention and early detection is improved by screening. Methods…”
Get full text

Inflammation-related proteins as biomarkers of treatment-related behavioral symptoms: A longitudinal study of breast cancer patients and age-matched controls by Patel, Sunita K., Breen, Elizabeth C., Paz, I. Benjamin, Kruper, Laura, Mortimer, Joanne, Wong, F. Lennie, Bhatia, Smita, Irwin, Michael R., Behrendt, Carolyn E.

“…Behavioral symptoms in breast cancer (BC) survivors have been attributed to cancer treatment and resulting inflammation. However, studies linking behavioral…”
Get full text

Objective physical and mental markers of self‐reported fatigue in women undergoing (neo)adjuvant chemotherapy for early‐stage breast cancer by Mortimer, Joanne E., Waliany, Sarah, Dieli‐Conwright, Christina M., Patel, Sunita K., Hurria, Arti, Chao, Joseph, Tiep, Brian, Behrendt, Carolyn E.

“…BACKGROUND Objective, treatment‐independent markers of cancer‐related fatigue are needed to advance clinical trials. In the current study, the authors…”
Get full text

Severe Hyperglycemia Immediately After Allogeneic Hematopoietic Stem-Cell Transplantation is Predictive of Acute Graft-Versus-Host Disease by Gebremedhin, Efrem, Behrendt, Carolyn E., Nakamura, Ryotaro, Parker, Pablo, Salehian, Behrouz

“…Stress hyperglycemia and acute graft- versus -host disease (GVHD), the major early complication of hematopoietic stem cell transplantation (HSCT), are both…”
Get full text

In vivo evidence insufficient to conclude that “KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission” by Behrendt, Carolyn E., Zaia, John A.

Get full text

Socioeconomic and clinical factors are key to uncovering disparity in accrual onto therapeutic trials for breast cancer by Behrendt, Carolyn E, Hurria, Arti, Tumyan, Lusine, Niland, Joyce C, Mortimer, Joanne E

“…To monitor and address disparity in accrual, patient participation in cancer clinical trials is routinely summarized by race/ethnicity. To investigate whether…”
Get more information

Donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after HLA-matched hematopoietic stem-cell transplantation: HLA-C allotype is an essential cofactor by Behrendt, Carolyn E, Nakamura, Ryotaro, Forman, Stephen J, Zaia, John A

“…Natural killer (NK) cells whose killer immunoglobulin-like receptors (KIRs) recognize human leukocyte antigen (HLA) ligand are "licensed" for activity. In…”
Get full text